Company intelligence / Profile preview

Thrombolex

Doylestown/New Britain, Pennsylvania, United Statesthrombolex.com ↗

Ownership: Private
Employees: ~16
Development stage: Commercial

Overview

Thrombolex has developed and commercialized multiple FDA-cleared endovascular catheters based on its BASHIR™ platform. Clinical studies—including the RESCUE trial—have shown marked reduction in right ventricular/left ventricular ratio and clot burden in patients with acute intermediate-risk pulmonary embolism. First-in-human results confirmed safety and feasibility of the device for pharmacomechanical catheter-directed thrombolysis. Ongoing trials aim to expand indications and optimize protocols for single-session treatment of PE.

Therapeutic areas: Cardiovascular
Modalities: Device (Endovascular catheter)Pharmaco-mechanical therapy (catheter-directed thrombolysis)
Industry: Surgical Medical Devices

Drug pipeline

3 assets

BASHIR Endovascular Catheter

Commercial

Indications: Pulmonary embolism, Deep vein thrombosis

2 more assets in the full pipeline.

Request access →

Partnerships

Aidoc (AI technology partnership to accelerate RAPID‑PE clinical trial enrollment)

Beyond the preview

Go deeper on Thrombolex.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thrombolex.

Explore the full profile